戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ular-weight SH2-targeted ligands for the Lck tyrosine protein kinase.
2 another Src family kinase or by an unrelated tyrosine protein kinase.
3 erformed exclusively by serine/threonine and tyrosine protein kinases.
4 ncentrations of several serine/threonine and tyrosine protein kinases.
5 in that is a substrate for Bcr-Abl and other tyrosine protein kinases.
6 nated between unrelated serine/threonine and tyrosine protein kinases.
7 s various forms by both serine/threonine and tyrosine protein kinases.
8  is mediated by members of the JAK family of tyrosine protein kinases.
9 he prototype of a novel type of regulator of tyrosine-protein kinases.
10  related genes and we identified a PTI1-like tyrosine-protein kinase 1 gene as a putative candidate g
11 ntracellular kinases, including Janus family tyrosine protein kinase 2, phosphoinositol-3 kinase, and
12                         We show that Abelson tyrosine-protein kinase 2 (Abl2) has a key role in regul
13 ally identified the imatinib target, Abelson tyrosine-protein kinase 2 (Abl2), as required for effici
14 s a transcript coding for the kinase Abelson Tyrosine-Protein Kinase 2 (ABL2), which we found to be n
15  GTPase RAB5 and the tyrosine kinase Abelson tyrosine-protein kinase (ABL), to modulate endocytosis a
16 lar aging in the mature brain and identified tyrosine-protein kinase Abl1 as an NSC aging factor.
17 creased aggregation and cellular and sarcoma tyrosine-protein kinase activation.
18 inding substance (LMWCr) does not effect the tyrosine protein kinase activity of rat adipocytic membr
19 rowth factors whose receptors have intrinsic tyrosine protein kinase activity, it is thought that Sta
20  protein kinase C activity, but did increase tyrosine protein kinase activity.
21 rca 250 pM, resulting in the increase of its tyrosine protein kinase activity.
22 DNA synthesis was prevented by inhibitors of tyrosine protein kinase and phosphatidylinositol (PI) 3-
23 ses that involves the activation of neuronal tyrosine protein kinases and among other functions regul
24  Both signals are sensitive to inhibitors of tyrosine protein kinases and require Ras activation via
25 he tyrosine kinases p60c-Src (proto-oncogene tyrosine-protein kinase) and the proline-rich tyrosine k
26 sine kinase, MuSK (muscle, skeletal receptor tyrosine-protein kinase), and Lrp4 (low-density lipoprot
27 mide, while toxicity was attenuated with the tyrosine protein kinase-antagonists herbimycin and genis
28    Members of the Src family of non-receptor tyrosine protein kinases are known to be inhibited by th
29 at least partially by associating with Janus tyrosine protein kinases at the conserved box one motif
30  of herpesvirus saimiri 484 binds to the Lck tyrosine-protein kinase at two sites and activates it dr
31 n-derived neurotrophic factor (BDNF) and its tyrosine protein kinase B (TrkB) receptors are known to
32 ti-CD19 monoclonal antibodies; inhibition of tyrosine-protein kinase BTK; CD40 ligand blockade; inter
33 nsfer by trogocytosis, regulated by receptor tyrosine-protein kinase C-Kit (CD117), from BM-resident
34 y that mutation in dual serine/threonine and tyrosine protein kinase (dstyk) lead to CS-like vertebra
35 d proteins predicted impaired cell survival (tyrosine-protein kinase, endothelial growth factors) and
36 ermal growth factor (EGF) receptor, receptor tyrosine-protein kinase erbB-2 (ERBB2)/human EGF recepto
37 rmline variant in ERBB3, coding for receptor tyrosine-protein kinase erbB-3 (ErbB3), was identified,
38 ed domain containing 1 (PTCHD1) and receptor tyrosine-protein kinase (ERBB4) during human thalamic de
39 ed neurotrophic factor (BDNF) and a receptor tyrosine-protein kinase, ERBB4, in the organoids.
40 te mutation in the dual serine-threonine and tyrosine protein kinase gene (DSTYK).
41                         Bmx/Etk non-receptor tyrosine protein kinase has been implicated in endotheli
42     The central role of serine/threonine and tyrosine protein kinases in signal transduction and cell
43 nsertion in DSTYK (dual serine-threonine and tyrosine protein kinase) in all four affected family mem
44 found that WASP binds readily to a number of tyrosine protein kinases including the Src kinases and t
45                                 Genistein, a tyrosine protein kinase inhibitor, blocked uptake of P.
46                                          Fyn tyrosine protein kinase is a potential mediator in T-cel
47                   Lck, a lymphocyte-specific tyrosine protein kinase, is bound to cellular membranes
48 1130 in the oncoprotein v-Fps, a nonreceptor tyrosine protein kinase, is predicted to interact with t
49                  Initial sorting is based on tyrosine-protein kinase Kit (c-Kit) expression that enri
50 egulation of DNA methyltransferase DNMT1 and tyrosine-protein kinase KIT, the enhanced phosphorylatio
51 reases the phosphorylation of the Src family tyrosine protein kinase Lck at Tyr-394, a conserved resi
52              This study assessed the role of tyrosine-protein kinase Lck (p56/Lck) in this pathway.
53  mitochondrial respiratory chain upstream of tyrosine-protein kinase Lyn, Lyn upstream of tyrosine-pr
54 ified proteolytic cleavage of proto-oncogene tyrosine-protein kinase MER (MERTK), a key anti-inflamma
55 tein tyrosine kinase (TYRO3), Proto-oncogene tyrosine-protein kinase MER (MERTK), and growth arrest-s
56 oxyacid oxidase 1, kidney injury molecule 1, tyrosine-protein kinase Mer, placental growth factor, th
57                 Here we identify two related tyrosine protein kinases, Mik1 from fission yeast and it
58 that this protein is the lymphocyte-specific tyrosine protein kinase p56lck.
59      Here, we report that a serine/threonine/tyrosine protein kinase phosphorylates oleosin.
60  cell systems and by a temperature-sensitive tyrosine protein kinase, pp60v-src in LA25-NRK cells.
61           The neurotrophin receptors p75 and tyrosine protein kinase receptor A (TrkA) play important
62 f receptors, the largest subgroup within the tyrosine protein kinase receptor family, are comprised o
63 esired activity on other kinases such as the tyrosine protein kinase receptor TIE or tropomyosin rece
64  CRISPR-Cas9 guide RNA screen and identified tyrosine protein kinase receptor UFO (AXL) as a proteina
65 Cbl-b act coordinately in the first steps of tyrosine protein kinase receptor-mediated signaling and
66 y correlated with the cell surface levels of tyrosine-protein kinase receptor UFO (AXL) receptor tyro
67                           Salivary levels of tyrosine-protein kinase receptor UFO (AXL), TYRO3 protei
68 ncoding EphA8, a member of the Eph family of tyrosine protein kinase receptors, previously known as E
69  by a DNA damage-responsive serine threonine/tyrosine protein kinase (RqkA).
70 addition of the myristoylation domain of the tyrosine protein kinase Src to their N termini.
71 0b, and miR31through cellular proto-oncogene tyrosine-protein kinase Src (cSrc)), response to growth
72              After MI, c-Src (proto-oncogene tyrosine-protein kinase Src) and its active form (phosph
73 of YES1, a member of the SRC (proto-oncogene tyrosine-protein kinase Src) family kinases (SFKs), can
74 cluded focal adhesion kinase, proto-oncogene tyrosine-protein kinase Src, and caveolin-1 (Cav-1), amo
75 ts atrasentan and zibotentan, proto-oncogene tyrosine-protein kinase (SRC) inhibitor dasatinib, and t
76                               Proto-oncogene tyrosine-protein kinase (Src) was identified as its memb
77 omologous to members of the serine/threonine/tyrosine protein kinase superfamily was recently identif
78 tyrosine-protein kinase Lyn, Lyn upstream of tyrosine-protein kinase SYK (Syk), and Syk upstream of n
79 through GPVI-FcRgamma and indicated that the tyrosine-protein kinase Syk is a key target of the regul
80                       c-src is a nonreceptor tyrosine protein kinase that is highly concentrated in s
81 n kinase kinase 3 (MKK3) is a dual threonine/tyrosine protein kinase that regulates inflammation, pro
82 en Nef is complexed to the SH3 domain of Hck tyrosine protein kinase, the peptide binds to the same s
83  we describe the profiling of a non-receptor tyrosine-protein kinase (TYK2) inhibitor which shows a f
84 ion and activation of the Src family and Syk tyrosine protein kinases, tyrosine phosphorylation of ph
85 ides by the kinase domain of the nonreceptor tyrosine protein kinase v-fps were measured using viscos
86 in the kinase domain of v-Fps, a nonreceptor tyrosine protein kinase, was analyzed using proton inven
87            In both contests, we employed the tyrosine-protein kinase Yes as an example target protein